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a  b  s  t  r  a  c  t
Disposable single-port surgery devices have been used for transanal minimally invasive
surgery  (TAMIS) with beneﬁts, when compared to local resection and transanal endoscopic
microsurgery  (TEM).
Objective:  To show outcomes and details of the technique.
Method:  A series of patients with indication for local resection of rectal tumors were  sub-
mitted  to surgery using the TAMIS platform.
Results: Eleven patients have been submitted to TAMIS. Distance from anal verge was from
1.5  to 8 cm and maximum tumor diameter was 6 cm. Initial diagnosis of adenoma was
the  most frequent indication for resection. One partial dehiscence was the only compli-
cation  seen. Minimal setup time, low cost and the possibility of using regular laparoscopic
instruments  make TAMIS a good option for transanal resection. The results of this tech-
nique  are encouraging, concerning the feasibility, maneuverability, upfront cost, setup time,
resectability and complication rate. Because of its simplicity and similarity with conven-
tional  laparoscopic surgery, it can be learned easily. Although at the present time the
appropriate  use of local excision is still under debate, TAMIS is a technique that still expects
a  lot of growing and much remains to be learned.© 2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 
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Cirurgia  Trans-anal  Minimamente  Invasiva  (CTAMI)  para  excisão  local  de






r  e  s  u  m  o
Dispositivos cirúrgicos de porta única descartáveis têm sido utilizados para a Cirurgia Trans-
anal Minimamente Invasiva (CTAMI) com benefícios, quando comparados com ressecc¸ão
local  e microcirurgia endoscópica trans-anal (MET).
Objetivo: Apresentar os desfechos e detalhes da técnica.
Método: Uma série de pacientes com indicac¸ão  para ressecc¸ão  local de tumores retais foi
tratada cirurgicamente pela plataforma CTAMI.
Resultados: Onze pacientes foram tratados por CTAMI. A distância a contar da margem
anal variou de 1,5 até 8 cm,  e o diâmetro máximo do tumor foi 6 cm.  Um diagnóstico ini-
cial de adenoma foi a indicac¸ão  mais frequente para a ressecc¸ão.  A única complicac¸ão
ocorrida  foi uma deiscência parcial. Mínimo tempo para preparac¸ão,  baixo custo e a pos-
sibilidade do uso de instrumentos laparoscópicos convencionais fazem de CTAMI uma  boa
opc¸ão  para a ressecc¸ão  trans-anal. Os resultados dessa técnica são animadores, no que
diz respeito à exeqüibilidade, manobrabilidade, custos iniciais, tempo de preparac¸ão,  res-
sectabilidade e percentual de complicac¸ões.  Grac¸as  à sua simplicidade e semelhanc¸a  com
a cirurgia laparoscópica convencional, CTAMI tem uma fácil curva de aprendizado. Embora
atualmente ainda seja motivo de discussão o uso apropriado da excisão local, CTAMI é uma
técnica que ainda provavelmente ainda crescerá muito–e há muito a ser aprendido.
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s screening has substantially increased the early diagnosis of
umors,  there is a need for local treatments that are oncolog-
cally  equivalent to radical surgery, but safer and functionally
uperior.1 Local excision of rectal tumors has been performed
ince  early 1800, when Lisfranc described a local resection for
ectal carcinoma.2
Transanal endoscopic microsurgery (TEM) was described
nitially by Gerhard Buess in 1983 to provide a means for
emoving benign lesions of mid  and upper rectum not easily
ccessible  by conventional methods.3
Compared to local excision, TEM provides superior qual-
ty  of resection, decreased local recurrence, and improved
urvival, particularly among patients with adenomas4 and
istologically favorable stage I rectal cancer.3,5 In long-term
ollow-up, TEM excision of rectal tumors has proven to be safe
nd  effective, with morbidity and mortality similar to that of
onventional  transanal excision.6,7
However, although TEM has been in use for more  than
0  years, it has been slow to become universally adopted by
olorectal  surgeons, partly due to a long learning curve, but
lso  because of the signiﬁcant cost of the highly specialized
quipment.2–4
As technology continues to undergo rapid evolution, the
inimally  invasive surgeons’ skills develop quickly. Recently
he  Natural Oriﬁce Transluminal Endoscopic Surgery (NOTES)
as  provided technology for developing permanent and dis-
osable  equipment and instruments that can be used for both
bdominal  and pelvic operations through a single incision.
hese  devices have facilitated a wide range of operations,including bariatric and all sorts of colorectal surgeries using a
single-incision mutiport device.
The working angles in single-access laparoscopy are essen-
tially  identical to those used in TEM. Therefore, crossover
exists between the skill set necessary to perform single-port
laparoscopy and TEM. The considerable upfront cost of TEM
instrumentation, however, remains a signiﬁcant barrier to its
widespread use.
Transanal  minimally invasive surgery (TAMIS) has been
described  ﬁrst by Dr. Attalah, Dr. Larach and Dr. Albert, from
Orlando,  FL,3 who reported this technique to be effective and
safe  for early rectal cancer and adenomas, with excellent oper-
ative  ﬁeld visibility and not technically difﬁcult. As the authors
say,  the TAMIS is a “giant leap forward” when compared to
TEM.  Mounting is easier and demands less time prior to begin-
ning  surgery; as it is a disposable device, the cost is much  lower
and  manipulation is much  more  comfortable than TEM.
Recently,  EthiconTM (Cincinnati, OH) presented their Single
SiteTM (SSL) device for NOTES. It has been designed for single-
incision laparoscopic abdominal surgeries, but has been also
used  successfully for TAMIS resection.8 A little later, GelPoint
PathTM has been launched by Applied Medical (Rancho Santa
Margarita, CA), speciﬁcally for TAMIS.
Methods
Over a 24-month period TAMIS has been offered to all patients
with  rectal lesions who were candidates for transanal local
resection  or abdominal anterior resection when carcinoma
was  excluded. Informed consent was obtained and all patients
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(10–60  mm).  Eight patients had an initial diagnosis of ade-
noma.  One patient had a previous endoscopic resection of
a  T1 adenocarcinoma (case C), made with mucosectomy
Fig. 2 – Adenoma with central focal pT1 after monopolar
marking.Fig. 1 – Ports placed. A,
were  given the option to undergo conventional surgery.
Patients with known malignant lesions were excluded.
From August 2010 to August 2013 all data of patients under-
going  this surgical technique, using both SSLTM and GelPoint
PathTM, was  collected prospectively. Follow-up was  for up
to  24 months. All patients had digital rectal examination or
colonoscopy  postoperativelly. Patients undergoing the tech-
nique  of TAMIS patients had adenomas with dysplasia of low
and  high grade, only one of them had a scar after incom-
plete endoscopic resection, and one as adenocarcinoma in
situ.  Patients having previous diagnosis of adenocarcinoma
underwent transrectal ultrasound to evaluate depth and nodal
invasion.
Surgical  procedures were performed at a tertiary-care Hos-
pital.  All patients were  administered general anesthesia. To
perform  the procedure the patient’s preferable position is one
in which the lesion is in the rectum wall that is closer to the
operating  table. When the lesion is in the posterior rectal wall,
the  patient is in lithotomy position, with legs up; when the
tumor  is in the right lateral wall, the patient can be turned with
the  right side down. Although not mandatory, this is the most
comfortable  way  to perform this procedure. Mechanical bowel
preparation  was  administered preoperatively and received a
single 3 g-dose of intravenous Unasyn® (Pﬁzer, Brazil), at anes-
thetic  induction.
After  insertion of the transanal port (either the SSLTM or
GelPoint PathTM, Fig. 1), the pneumorectum was  gained using
CO2 insufﬂation with an initial pressure set a 12 mmHg  and
ﬂow  set at 40 mmHg  per minute. Standard straight laparo-
scopic  instruments were used. Full-thickness excision was
performed  on all lesions aiming a 1 cm minimum nega-
tive  margin (Fig. 2). All defects were  closed completely with
absorbable  suture material (Fig. 3).
Patients had a planned discharge for the next day of
surgery.
ResultsEleven patients aged 50–86 years (average 67.4 y) under-
went  TAMIS resection of rectal lesions (Table 1). The average
distance  from anal verge was  47.7 mm (15–80 mm)  and theTM; B, GelPoint PathTM.
mean  tumor diameter measured by pathology was 35 mmFig. 3 – Suturing after full-thickness resection of a 5 cm
tumor.
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Table 1 – Tumor characteristics.







Resection  margin Final tumor
pathology
A, 51/M 15 Vilous adenoma Posterior 30 Free Adenocarcinoma
T1
B, 76/M 25 Vilous adenoma Left lateral 50 Free Tubule-vilous
adenoma






Left  lateral (no
visible  tumor,
only  scar)
20  (scar) Free Free from tumor
D, 63, F 10 No AP inicial Left posterior 20 Free Free from tumor
E, 78/M 60 Tubule-vilous
adenoma
Posterior 60  Free Adenocarcinoma
T2
F, 81/M 50 Tubulo-vilous
adenoma, high
grade  dysplasia
Circumferentiala Circumferential Partially resected Tubulo-vilous
adenoma
G, 66, F 30 Vilous adenoma Right posterior 50 Free Tubulo-vilous
adenoma
H, 86, F 40 Vilous adenoma Right posterior 50 Positive Adenocarcinoma
Tis
I, 52, M 10 Tubule-vilous
adenoma
Anterior  40 Not resected (a)
J, 65, M 50 Vilous adenoma Left posterior 40 Positive Adenocarcinoma
Tis
K, 74, F 80 Adenocarcinoma
in situ
Anterior  40 Free Vilous adenoma































A 55 1 None
B 50 1 None
C 45 1 None
D 45 1 None
E 80 1 None
F 40 1 None
G 47 1 None
H 60 1 None
I Not performed Not operated Nonea After positioning the patient the device could not be positioned an
echnique and had positive margins. This patient was eligible
or  scar resection with larger margins. No tumor was  found by
he pathologist in this patient.
One patient (case D) could not be operated by the described
echnique. Expansion of the SSLTM retractor into rectal lumen
as  not possible. The size of the prostate occupying the rectal
umen  was  probably responsible for not allowing the device to
pen toward the anterior rectal wall and thus a conventional
ocal excision was  used instead.
Another patient (case F) was  under evaluated during pre-
perative  colonoscopy, as the tumor was  described as lateral,
nd  during surgery it showed as circumferential. In this case
t  was  resected partially, only for ensuring pathologic diag-
osis,  and further taken to laparoscopic anterior resection
ith  colonic pouch-anal anastomosis. Pathologic specimen
howed  tubulo-vilous adenoma.
Setup time varied from 1 to 45 min  (average 9.8 min), and
otal  surgery time was  from 38 to 80 min  (average 51 min). Two
f  the ten resected specimens contained early stage adenocar-
inomas.  All margins were free (Table 2).
Once the resection was  completed, the defect was  approx-
mated  with intraluminal suture. In nine patients the option
as  to place metallic clips on both edges of the suture, instead
f  tying. One patient had ties done on the suture’s edges.
All  patients stayed overnight and were discharged the next
orning.
As  the only known complication, one patient had a par-
ial  dehiscence of the suture line in distal rectum diagnosed
n  ninth post-operative day, and was  treated without surgicalJ 50 1 None
K 38 1 None
re-intervention. In this patient, scar completion took about 45
days.
Discussion
Although TEM has been proven to be an effective alternative
for  local excision and is being performed for more  than 30
years,  which is before the widespread use of laparoscopic tech-
niques for abdominal surgeries, the advancements in the TEM
technique  remained almost the same and did not follow what
happened  to abdominal laparoscopy. Before TAMIS was  pre-
sented  in 2010, the only evolution in transanal surgery was
the  development of rigid metal or transparent9 proctoscopes
j). 2 0
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for TEM. When TAMIS was  ﬁrst described, the world became
aware  of a completely new technique using an affordable, sim-
ple, easy-to-use and effective device.
Care must be taken in patient selection, as local exci-
sion  must be considered only for early rectal cancer with
no  evidence of nodal metastasis,5,10 parameters that can be
predicted  by clinical and radiological evaluation.11,12 Even
after  adequate pre-operative evaluation, up to 44.3% of T1
tumors  can be misevaluated pre-operatively.1,13 Although all
patients  were  submitted to surgery with a tumor thought to
be  benign, one had a T1 and the other a T2 tumor. As onco-
logical  safety for local resection for T2 tumors is not well
stablished,1,14–17 this last one was  further taken to laparo-
scopic anterior resection with colo-anal anastomosis and
pathology  showed no residual carcinoma or positive lymphn-
odes  (pT0 N0) in the surgical specimen.
A tip to be learned is that the prostate volume should be
evaluated  pre-operatively, as it can be limiting for the tech-
nique.
Considering  the minimal setup time, low cost and specially
the  adaptation of regularly used laparoscopic instruments,
TAMIS provides an ideal platform for transrectal or transanal
resection.18 It has also been used for other diseases, such
as  high ﬁstulas and distal rectal mobilization for coloanal
anastomosis19 and carcinoid tumors resection.20,21 Other
indications that lack consensus are re-excision following
endoscopic removal of malignant polyps22 and excision of
downstaged tumor or scar after complete response to neoad-
juvant  chemo/radiotherapy.13,23–25 Recently, total mesorectal
excision performed by TAMIS showed to be feasible and
promises  good future results.
In this series, maximum distance from tumor to anal verge
was  8 cm.  This patient had a 5 cm diameter tumor, so resection
was  up to 14 cm from anal verge, considering margins, without
difﬁculties,  showing that its use must not be restricted to low
tumors,  as suggested before.26
The advantages of TAMIS over TEM are well described:3,27
• Devices used for TAMIS are pliable and allow well-ﬁtted
positioning at the anal canal, possibly leading to less impair-
ment  of sphincter function than the 40 mm rigid scope used
for  TEM.
•  Setup time is signiﬁcantly lower for TAMIS.
• Possibility to use regular straight laparoscopic instruments
and  a standard 30◦ laparoscope, as opposed to the ﬁxed eye-
piece  of the TEM rectoscope, which enables advancement
of  the scope into the proximal rectum and sigmoid, thereby
allowing the surgeon to look beyond the tumor.
• It can be easily learned by surgeons not used to TEM
technique due to its potential instrumental simplicity and
similarity  with conventional laparoscopic surgery. Larger
ports,  up to15 mm port are available only for TAMIS
devices, and it can be very helpful when a 12-mm sta-
pler  is needed (e.g. for safe resection of a big pedunculated
polyp).
•  Cost makes SSLTM and GelPoint PathTM very comfort-
28able, safe and cost-effective alternatives for TEM. When
abdominal resection is considered for adenomas or T1
tumors  that are from dentate line up to higher rectum, or
even  if future studies show that selected T2 and T3 tumors 1 4;3  4(3):148–153
can be locally controlled,1,14,16,29 TAMIS devices can be a
remarkable cost-effective alternative.
• The cap can be removed and re-located quickly, when
needed. It can be removed for specimen retrieval and repo-
sitioned  in less than 1 min  for suturing.
•  Positioning the device takes usually less than 1 min.
• Due to its design, there is no need for investment in special
curved  instruments. All regular laparoscopic instruments
can  be used.
•  The repositionable cap allows changing of instrument posi-
tion  without having to reinsert the device.
• As the devices are basically a hollow sleeve with a cap in
which  the ports are located, there is no resistance when
moving around the instruments. This makes the use of reg-
ular  straight laparoscopic instruments easier than TEM or
SILSTM (Covidien, Mansﬁeld, MA).
Conclusions
Although at present time the appropriate use of local excision
is  still under debate, TAMIS is a technique that has a potential
of  increased application and much  remains to be learned. Like
others,3,27 our group is optimistic that TAMIS came as a good
alternative to TEM and also as one of the most important con-
tributions  for transanal surgery in the last decades years. Its
reduced  cost and simplicity shall allow surgeons to learn the
technique  quite easily. Despite simplicity, care must be taken
in  patient selection, as pre-operative staging is frequently an
understaging of tumors.
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